Evidence map›Paper›PMID 33050503›Full record

ArticleInternational journal of molecular sciences2020

Modulation of Actin Filament Dynamics by Inward Rectifying of Potassium Channel Kir2.1.

Lida Wu, Quanyi Wang, Junzhong Gu, Huiyuan Zhang, Yuchun Gu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Lida WuMolecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Quanyi WangDepartment of Biopharmaceutics, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
Junzhong GuMolecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Huiyuan ZhangMolecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Yuchun GuMolecular Pharmacology Laboratory, Institute of Molecular Medicine, Peking University, Beijing 100871, China.
Peking University · CNAston University · GBChina Pharmaceutical University · CN

Funding

National key basic research and development plan (973 Program) 973 Project No. 2012CB517803National key basic research and development plan (973 Program) No. 2013CB531206National Natural Science Foundation of China No.31127001National Natural Science Foundation of China No.81170236,
6 · The paper itself

Abstract

Apart from its ion channel properties, the Kir2.1 channel has been found in tumors and cancer cells to facilitate cancer cell motility. It is assumed that Kir2.1 might be associated with cell actin filament dynamics. With the help of structured illumination microscopy (SIM), we show that Kir2.1 overexpression promotes actin filament dynamics, cell invasion, and adhesion. Mutated Kir2.1 channels, with impaired membrane expression, present much weaker actin regulatory effects, which indicates that precise Kir2.1 membrane localization is key to its actin filament remolding effect. It is found that Kir2.1 membrane expression and anchoring are associated with PIP

Indexed as

Ion Channel GatingActin CytoskeletonActinsAquaporinsCell AdhesionCell LineCell MembraneCell MovementFluorescent Antibody TechniqueGene ExpressionHumansPhosphorylationPotassium Channels, Inwardly RectifyingProtein BindingActinsAquaporinsKir2.1 channelPotassium Channels, Inwardly Rectifyingactin filament dynamicsfilamin AKir2.1PIP2

Identifiers

PMID33050503
PMCPMC7589188
OpenAlexW3092618544

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.